Oppenheimer Holdings, Inc. Analysts Give Wright Medical Group N.V. (WMGI) a $30.00 Price Target

Oppenheimer Holdings, Inc. set a $30.00 target price on Wright Medical Group N.V. (NASDAQ:WMGI) in a report published on Thursday, August 3rd. The brokerage currently has a hold rating on the medical device company’s stock.

A number of other research firms also recently commented on WMGI. Needham & Company LLC reaffirmed a hold rating on shares of Wright Medical Group N.V. in a research report on Thursday, May 4th. Cantor Fitzgerald started coverage on shares of Wright Medical Group N.V. in a research report on Thursday, June 29th. They issued an overweight rating and a $33.00 target price on the stock. BidaskClub downgraded shares of Wright Medical Group N.V. from a hold rating to a sell rating in a research report on Saturday, June 10th. BMO Capital Markets reaffirmed a buy rating and issued a $34.00 target price on shares of Wright Medical Group N.V. in a research report on Thursday, May 4th. Finally, Jefferies Group LLC increased their target price on shares of Wright Medical Group N.V. from $30.00 to $33.00 and gave the company a buy rating in a research report on Thursday, May 4th. Six investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus target price of $32.25.

Shares of Wright Medical Group N.V. (NASDAQ:WMGI) opened at 27.80 on Thursday. The firm has a 50-day moving average of $27.24 and a 200 day moving average of $27.94. Wright Medical Group N.V. has a 52 week low of $20.50 and a 52 week high of $31.53. The company’s market cap is $2.90 billion.

Wright Medical Group N.V. (NASDAQ:WMGI) last announced its quarterly earnings data on Wednesday, August 2nd. The medical device company reported ($0.07) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.09) by $0.02. The company had revenue of $179.69 million for the quarter, compared to the consensus estimate of $178.17 million. Wright Medical Group N.V. had a negative net margin of 36.04% and a negative return on equity of 6.22%. The company’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.11) EPS. Equities analysts expect that Wright Medical Group N.V. will post ($0.29) EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Oppenheimer Holdings, Inc. Analysts Give Wright Medical Group N.V. (WMGI) a $30.00 Price Target” was originally posted by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this story on another domain, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The legal version of this story can be accessed at https://transcriptdaily.com/2017/08/13/wright-medical-group-n-v-wmgi-given-a-30-00-price-target-at-oppenheimer-holdings-inc-updated.html.

In other Wright Medical Group N.V. news, VP Julie Andrews sold 1,480 shares of the firm’s stock in a transaction on Friday, June 2nd. The shares were sold at an average price of $27.11, for a total transaction of $40,122.80. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Lance A. Berry sold 6,685 shares of the firm’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $27.14, for a total transaction of $181,430.90. The disclosure for this sale can be found here. Insiders have sold a total of 40,655 shares of company stock worth $1,116,708 over the last three months. 9.30% of the stock is currently owned by insiders.

Several hedge funds have recently added to or reduced their stakes in WMGI. Blue Jay Capital Management LLC boosted its stake in Wright Medical Group N.V. by 4.7% in the second quarter. Blue Jay Capital Management LLC now owns 320,420 shares of the medical device company’s stock valued at $8,808,000 after buying an additional 14,255 shares during the period. Renaissance Technologies LLC boosted its stake in Wright Medical Group N.V. by 139.9% in the second quarter. Renaissance Technologies LLC now owns 1,209,407 shares of the medical device company’s stock valued at $33,247,000 after buying an additional 705,300 shares during the period. Parametric Portfolio Associates LLC boosted its stake in Wright Medical Group N.V. by 8.9% in the second quarter. Parametric Portfolio Associates LLC now owns 47,233 shares of the medical device company’s stock valued at $1,298,000 after buying an additional 3,871 shares during the period. Quantbot Technologies LP purchased a new stake in Wright Medical Group N.V. during the second quarter valued at approximately $410,000. Finally, California Public Employees Retirement System boosted its stake in Wright Medical Group N.V. by 2.6% in the second quarter. California Public Employees Retirement System now owns 188,140 shares of the medical device company’s stock valued at $5,172,000 after buying an additional 4,700 shares during the period.

Wright Medical Group N.V. Company Profile

Wright Medical Group, Inc is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients’ lifestyles. The Company operates through three segments: U.S., International and BioMimetic.

Analyst Recommendations for Wright Medical Group N.V. (NASDAQ:WMGI)

Receive News & Ratings for Wright Medical Group N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wright Medical Group N.V. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply